NCT06280755Recruiting
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study
Source: ClinicalTrials.gov · Last updated 12 Dec 2025
Brief summary (registry, in English)
The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 7000 (estimated)
- First submitted
- 23 Jan 2024
- Start date
- 1 Mar 2024
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- icometrix
- Diseases
- Multiple sclerosis
- NCT number
- NCT06280755
What you commit to
- Study type: Observational
- Planned participants: 7000
- From 1 Mar 2024 to the primary completion date, 30 Apr 2027
- 3 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients under 18 years of age will be excluded.
Other
- Other unspecified reasons that, in the opinion of the Investigator or Joint Steering Committee, make the patient unsuitable for participation in the study.
Who the study is looking for
- Patients must have a confirmed diagnosis of MS, NMOSD, MOGAD, CIS or RIS.
- Patient (or patient's legal representative) has previously signed and dated an informed consent form (ICF) for the secondary use of their data, or assent form. Alternatively, the secondary use of the patient's data is allowed following Institutional Review Board (IRB)/Ethical Committee (EC) approval in accordance with national and local subject privacy regulations.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| General University Hospital Prague Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
| ERC Charité - Universitätsmedizin Berlin Coordinator of this site? Confirm its status | Berlin | Germany | Recruiting |
| Katholisches Klinikum Bochum - St. Joseph-Hospital Coordinator of this site? Confirm its status | Bochum | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.